# Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease

> **NCT00600951** · — · COMPLETED · sponsor: **Bracco Diagnostics, Inc** · enrollment: 366 (actual)

## Conditions studied

- Renal Insufficiency

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00600951
- **Lead sponsor:** Bracco Diagnostics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 366 (ACTUAL)
- **Last updated:** 2014-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00600951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00600951, "Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT00600951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*